← Back to search

Federal

Research on Complex Generics

Stephanie Bogan Grantor · RFA-FD-27-001

About this opportunity

The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.

Who can apply

  • Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional eligibility information: Only the following applicant is eligible to apply for this single source funding: The University of Maryland

Each funder sets its own eligibility, so check the details on their page before you apply.